NCT04390022View on ClinicalTrials.gov

Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2020

Primary Completion Date

September 17, 2020

Study Completion Date

October 9, 2020

Conditions
Covid-19Coronavirus InfectionSARS-CoV-2 Infection
Interventions
DRUG

Ivermectin

Single dose of STROMECTOL® tablets at 400mcg/kg

DRUG

Placebo

Placebo tablets will not match ivermectin but they will be administered by staff not involved in the clinical care.

Trial Locations (1)

31108

Clinica Universidad de Navarra, Pamplona

All Listed Sponsors
collaborator

Barcelona Institute for Global Health

OTHER

lead

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

NCT04390022 - Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial | Biotech Hunter | Biotech Hunter